PGR is 27% off it's float price which was just over 4 months ago. Given the current share price I think holders would be happy to see 10-15% down.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025